Details

Nacionalnovarnostna strategija Ruske federacije po koncu hladne vojne : diplomsko delo
ID Majcen, Gregor (Author), ID Vegič, Vinko (Mentor) More about this mentor... This link opens in a new window, ID Grošelj, Klemen (Comentor)

URLURL - Presentation file, Visit http://dk.fdv.uni-lj.si/diplomska/pdfs/majcen-gregor.pdf This link opens in a new window

Language:Slovenian
Keywords:Ruska federacija, Russian Federation
Work type:Undergraduate thesis
Typology:2.11 - Undergraduate Thesis
Organization:FDV - Faculty of Social Sciences
Place of publishing:Ljubljana
Publisher:[G. Majcen]
Year:2012
Number of pages:77 f.
PID:20.500.12556/RUL-19951 This link opens in a new window
UDC:355.02(470)(043.2)
COBISS.SI-ID:31206237 This link opens in a new window
Publication date in RUL:11.07.2014
Views:2411
Downloads:282
Metadata:XML DC-XML DC-RDF
:
MAJCEN, Gregor, 2012, Nacionalnovarnostna strategija Ruske federacije po koncu hladne vojne : diplomsko delo [online]. Bachelor’s thesis. Ljubljana : G. Majcen. [Accessed 3 April 2025]. Retrieved from: http://dk.fdv.uni-lj.si/diplomska/pdfs/majcen-gregor.pdf
Copy citation
Share:Bookmark and Share

Similar documents

Similar works from RUL:
  1. Načrtovanje sončne elektrarne in baterijskega hranilnika s ciljem energetske samooskrbe podjetja
  2. Analiza investicij v sončne elektrarne v Sloveniji
  3. Vpliv hlajenja fotonapetostnih celic na njihovo vršno moč in proizvodnjo električne energije
  4. Projektno učno delo s pomočjo 3D tiska v 8. razredu osnovne šole
  5. Pridobivanje energije s pomočjo sončnih celic na izbrani kmetiji
Similar works from other Slovenian collections:
  1. Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small cell lung cancer
  2. Outsourcing predictive biomarker testing in non-small cell carcinoma
  3. Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  4. Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  5. NSCLC molecular testing in Central and Eastern European countries

Back